Top Markets
Coin of the day
Aptose Biosciences Inc. Aptose Biosciences Inc.

Aptose Biosciences Inc.

APS
Pozycja w akcjach #35076
Aptose Biosciences Inc. is a clinical-stage biotechnology firm dedicated to... Aptose Biosciences Inc. is a clinical-stage biotechnology firm dedicated to discovering and advancing personalized therapeutic solutions for challenging oncology cases, primarily within the United States. Its robust pipeline features several key clinical programs: APTO-253, currently in Phase 1a/b trials, targets patients with relapsed or refractory blood cancers like acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS). Another candidate, HM43239, is undergoing Phase 1/2 evaluation for the treatment of relapsed or refractory AML. Aptose is also developing luxeptinib, which is in Phase 1a/b clinical studies for individuals battling relapsed or refractory B-cell malignancies, encompassing chronic lymphocytic leukemia, small lymphocytic lymphoma, various non-Hodgkin's lymphomas, as well as AML and HR MDS. Furthermore, the company is progressing with APL-581, a program centered on a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor. Aptose maintains strategic alliances with CrystalGenomics, Inc. and OHM Oncology. Incorporated in 1986 and headquartered in Toronto, Canada, the company was formerly known as Lorus Therapeutics Inc., changing its name to Aptose Biosciences Inc. in August 2014.
Cena akcji
$1.76
Ostatnia synchronizacja: 2026-07-03
Kapitalizacja rynkowa
$4.50M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
41.53%
Kraj
CA
Handel Aptose Biosciences Inc. (APS)

Kategoria

Historia ceny akcji dla Aptose Biosciences Inc. (APS)
Najwyższa cena zamknięcia: $1.76 dnia 2026-07-01

Najniższa cena zamknięcia: $4.49K dnia 1996-04-01
Historia cen akcji firmy Aptose Biosciences Inc. od 1996 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -4.34%
2025 677.87%
2024 -91.63%
2023 -72.76%
2022 -64.07%
2021 -64.29%
2020 12.71%
2019 99.28%
2018 11.56%
2017 62.99%
2016 -55.72%
2015 -58.73%
2014 -1.07%
2013 57.23%
2012 69.88%
2011 -81.30%
2010 -47.11%
2009 58.35%
2008 -77.14%
2007 -10.06%
2006 -14.70%
2005 -57.23%
2004 -28.50%
2003 124.84%
2002 -54.03%
2001 -22.17%
2000 55.42%
1999 161.59%
1998 -65.73%
1997 -16.29%
1996 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE